Biologics Contract Manufacturing Market Size, Share & Trends Report

Biologics Contract Manufacturing Market (2025 - 2030) Size, Share & Trends Analysis Report By Product (MABs, Recombinant Protein), By Indication (Oncology, CVDs), By Region, And Segment Forecasts

Market Segmentation

Biologics contract manufacturing Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
- Monoclonal Antibodies (mAbs)
- Recombinant Proteins
- Vaccines
- Antisense, RNAi, & Molecular Therapy
- Others
Biologics contract manufacturing Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Neurology
- Others
Biologics contract manufacturing Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America biologics contract manufacturing market, by product
    - Monoclonal Antibodies (mAbs)
    - Recombinant Proteins
    - Vaccines
    - Antisense, RNAi, & Molecular Therapy
    - Others
  - North America biologics contract manufacturing market, by Indication
    - Oncology
    - Autoimmune Diseases
    - Infectious Diseases
    - Cardiovascular Diseases
    - Metabolic Diseases
    - Neurology
    - Others
  - U.S.
    - U.S. biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - U.S. biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - Canada
    - Canada biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Canada biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - Mexico
    - Mexico biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Mexico biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
- Europe
  - Europe biologics contract manufacturing market, by product
    - Monoclonal Antibodies (mAbs)
    - Recombinant Proteins
    - Vaccines
    - Antisense, RNAi, & Molecular Therapy
    - Others
  - Europe biologics contract manufacturing market, by Indication
    - Oncology
    - Autoimmune Diseases
    - Infectious Diseases
    - Cardiovascular Diseases
    - Metabolic Diseases
    - Neurology
    - Others
  - UK
    - UK biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - UK biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - Germany
    - Germany biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Germany biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - France
    - France biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - France biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - Italy
    - Italy biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Italy biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - Spain
    - Spain biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Spain biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - Denmark
    - Denmark biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Denmark biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - Sweden
    - Sweden biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Sweden biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - Norway
    - Norway biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Norway biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
- Asia Pacific
  - Asia Pacific biologics contract manufacturing market, by product
    - Monoclonal Antibodies (mAbs)
    - Recombinant Proteins
    - Vaccines
    - Antisense, RNAi, & Molecular Therapy
    - Others
  - Asia Pacific biologics contract manufacturing market, by Indication
    - Oncology
    - Autoimmune Diseases
    - Infectious Diseases
    - Cardiovascular Diseases
    - Metabolic Diseases
    - Neurology
    - Others
  - Japan
    - Japan biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Japan biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - China
    - China biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - China biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - India
    - India biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - India biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - Australia
    - Australia biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Australia biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - Thailand
    - Thailand biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Thailand biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - South Korea
    - South Korea biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - South Korea biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
- Latin America
  - Latin America biologics contract manufacturing market, by product
    - Monoclonal Antibodies (mAbs)
    - Recombinant Proteins
    - Vaccines
    - Antisense, RNAi, & Molecular Therapy
    - Others
  - Latin America biologics contract manufacturing market, by Indication
    - Oncology
    - Autoimmune Diseases
    - Infectious Diseases
    - Cardiovascular Diseases
    - Metabolic Diseases
    - Neurology
    - Others
  - Brazil
    - Brazil biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Brazil biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - Argentina
    - Argentina biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Argentina biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
- Middle East & Africa
  - Middle East & Africa biologics contract manufacturing market, by product
    - Monoclonal Antibodies (mAbs)
    - Recombinant Proteins
    - Vaccines
    - Antisense, RNAi, & Molecular Therapy
    - Others
  - Middle East & Africa biologics contract manufacturing market, by Indication
    - Oncology
    - Autoimmune Diseases
    - Infectious Diseases
    - Cardiovascular Diseases
    - Metabolic Diseases
    - Neurology
    - Others
  - South Africa
    - South Africa biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - South Africa biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - Saudi Arabia
    - Saudi Arabia biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Saudi Arabia biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - UAE
    - UAE biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - UAE biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others
  - Kuwait
    - Kuwait biologics contract manufacturing market, by product
      - Monoclonal Antibodies (mAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Kuwait biologics contract manufacturing market, by Indication
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Cardiovascular Diseases
      - Metabolic Diseases
      - Neurology
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments